Table 3.
Analyses | 24‐mo WOMAC Pain | 24‐mo WOMAC Function | ||||
---|---|---|---|---|---|---|
Group 1: Optimal Early Pain Improvement (n = 67) | Group 2: Suboptimal Early Pain Improvement (n = 40) | P | Group 1: Optimal Early Functional Improvement (n = 66) | Group 2: Suboptimal Early Functional Improvement (n = 41) | P | |
Unadjusted analysis, mean (SE), median | 3.1 (0.9), 0 | 11.7(3.6), 5 | 0.005 | 3.7 (1.0), 0.7 | 16.9 (3.4), 13.2 | 0.000 |
Adjusted analysis, mean (SE) | 4.0 (1.5) | 11.6 (2.1) | 0.004 | 5.6 (1.5) | 15.1 (2.1) | 0.001 |
Adjusted analysis after MI, mean (SE) | 8.0(3.0) | 14.2 (3.2) | 0.033 | 10.9 (2.2) | 17.9 (2.1) | 0.008 |
Abbreviation: MI, multiple imputation.